Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer

✍ Scribed by Meyerhardt, J.; Stuart, K.; Fuchs, C.; Zhu, A.; Earle, C.; Bhargava, P.; Blaszkowsky, L.; Enzinger, P.; Mayer, R.; Battu, S.; Lawrence, C.; Ryan, D.

• Book ID: 125447199
• Publisher: Oxford University Press
• Year: 2007
• Tongue: English
• Weight: 84 KB
• Volume: 18
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdm124